Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Catecholaminergic polymorphic ventricular

The serum potassium concentration was 2.6 mmol/1. Catecholaminergic polymorphous ventricular tachycardia was later diagnosed. [Pg.399]

RYR2 DISEASE CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)... [Pg.295]

Aizawa, Y., Ueda, K., Komura, S., Washizuka, T., Chinushi, M., Inagaki, N., Matsumoto, Y., Hayashi, T. and M. Takahashi, Nakano, N., Yasunami, M., Kimura, A., and Hiraoka, M. (2005). A Novel Mutation in FKBP12.6 Binding Region of the Human Cardiac Ryanodine Receptor Gene (R2401H) in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia. Int J Cardiol 99(2) 343-5. [Pg.307]

Hasdemir, C., Priori, S. G., Overholt, E., and Lazzara, R. (2004) Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder. J Cardiovasc Electrophysiol 15(6) 729. [Pg.312]

Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., Cruz Filho, F. E., Vignati, G., Benatar, A., and DeLogu, A. (2002). Clinical and Molecular Characterization of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 106(1) 69-74. [Pg.316]

Sumitomo, N., Harada, K., Nagashima, M., Yasuda, T., Nakamura, Y., Aragaki, Y., Saito, A., Kurosaki, K., Jouo, K., Koujiro, M., Konishi, S., Matsuoka, S., Oono, T., Hayakawa, S., Miura, M., Ushinohama, H., Shibata, T., and Niimura, I. (2003). Catecholaminergic Polymorphic Ventricular Tachycardia Electrocardiographic Characteristics and Optimal Therapeutic Strategies to Prevent Sudden Death. Heart 89(1) 66-70. [Pg.318]

Leenhardt, A., Lucet, V., Denjoy, I., etal., 1995, Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation, 91(5), pp 1512-9. [Pg.535]

APD, action potential duration ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy CM, cardiomyocyte CPVT, catecholaminergic polymorphic ventricular tachycardia DAD, delayed after depolarizations DCM, dilated cardiomyopathy EAD, early after depolarization HCM, hypertrophic cardiomyopathy 1 rectifier potassium current 1, sodium current MEA, multielectrode array TNNT2, troponin T type 2. [Pg.352]

K. Kujala, J. Paavola, A. Lahti, K. Larsson, M. Pekkanen-Mattila, M. Viitasalo, A. M. Lahtinen, L. Toivonen, K. Kontula, H. Swan, CeU model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS One 7, e44660 (2012). [Pg.361]

Congenital complete heart block Peripartum cardiomyopathy Myocarditis Coronary anomalies Bragada syndrome Wolff-Parkinson-White syndrome Catecholaminergic polymorphic ventricular tachycardia... [Pg.497]


See other pages where Catecholaminergic polymorphic ventricular is mentioned: [Pg.335]    [Pg.335]    [Pg.1488]    [Pg.277]    [Pg.278]    [Pg.273]    [Pg.273]    [Pg.295]    [Pg.313]    [Pg.316]    [Pg.533]    [Pg.335]    [Pg.335]    [Pg.349]    [Pg.350]    [Pg.361]    [Pg.523]   


SEARCH



Catecholaminergic polymorphic ventricular tachycardia

Ventricular

© 2024 chempedia.info